Cardiogeni PLC (OFEX: CGNI)
Health Care · Biotechnology · GB
£0.07
0.00% today · -22.2% 1Y
Public summary
A free snapshot of Cardiogeni PLC, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Cardiogeni PLC (OFEX: CGNI) operates in the Biotechnology industry within the Health Care sector. The company is valued at $8.84M.
Over the last twelve months the share price has lost 22.2%, trading between 0.07 and 0.09.
Tweenvest scores Cardiogeni PLC across four factors: quality 66/100, value 58/100. Its strongest factor is quality.
CGNI price history
Key figures
- Market cap
- $8.84M
- Revenue (TTM)
- $10.07M
- P/E
- -25.18
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- £0.09
- 52-week low
- £0.07
- Avg volume (3M)
- —
- Shares outstanding
- 96.15M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Active Biotech AB (publ)OM: ACTI | $9.13M | Skr3.50 | -0.28% |
| Biovica International AB (publ)OM: BIOVIC B | $8.97M | Skr0.31 | -4.94% |
| Poxel S.A.ENXTPA: POXEL | $8.91M | €0.15 | -1.96% |
| IN8bio, Inc.NasdaqCM: INAB | $8.86M | $0.82 | +0.49% |
| 1nKemia IUCT Group, S.A.BME: IKM | $8.80M | €0.31 | 0.00% |
| Radiopharm Theranostics LimitedASX: RAD | $8.79M | AU$0.00 | -25.00% |
| Patrys LimitedASX: PAB | $8.75M | AU$0.02 | -2.17% |
| Intensity Therapeutics, Inc.NasdaqCM: INTS | $8.72M | $2.64 | -1.12% |